Bacil-Pharma (4)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces changes to the Long Term ASM Framework effective March 09, 2026, including 2 new securities shortlisted, 6 securities moved to … | |||||||||||||||
BSE announces changes to the Long Term ASM Framework effective March 09, 2026, including 2 new securities shortlisted, 6 securities moved to lower ASM stages, and 25 securities moving out of the framework.
| |||||||||||||||
BSE announces securities being added to, moved within, and removed from the Long Term Additional Surveillance Measure (LT-ASM) framework … | |||||||||||||||
BSE announces securities being added to, moved within, and removed from the Long Term Additional Surveillance Measure (LT-ASM) framework effective March 09, 2026.
| |||||||||||||||
BSE surveillance clarifications from Lippi Systems Limited, Aegis Logistics Ltd, and Bacil Pharma Ltd regarding unusual price and volume … | |||||||||||||||
BSE surveillance clarifications from Lippi Systems Limited, Aegis Logistics Ltd, and Bacil Pharma Ltd regarding unusual price and volume movements in their equity shares.
| |||||||||||||||
BSE surveillance clarifications from Lippi Systems Limited, Aegis Logistics Ltd., and Bacil Pharma Ltd. regarding unusual price or volume … | |||||||||||||||
BSE surveillance clarifications from Lippi Systems Limited, Aegis Logistics Ltd., and Bacil Pharma Ltd. regarding unusual price or volume movements in their equity shares, with all companies confirming no undisclosed material information.
| |||||||||||||||